文章摘要
89SrCl2治疗恶性肿瘤骨转移的影响因素分析
Analysis of influencing factors of strontium-89 in treatment of bone metastases of malignant tumors
投稿时间:2017-10-17  
DOI:10.3969/j.issn.1000-0399.2018.06.013
中文关键词: 肿瘤骨转移  89SrCl2  疗效  影响因素
英文关键词: Bone metastases  89SrCl2  Clinical effects  Influencing factors
基金项目:
作者单位E-mail
周莉 637000 四川南充 川北医学院附属医院核医学科  
庞骁 637000 四川南充 川北医学院附属医院核医学科  
陈勇 637000 四川南充 川北医学院附属医院核医学科  
许莉 637000 四川南充 川北医学院附属医院核医学科  
李素平 637000 四川南充 川北医学院附属医院核医学科 suping7273@163.com 
摘要点击次数: 1677
全文下载次数: 0
中文摘要:
      目的 探讨89SrCl2治疗恶性肿瘤骨转移的疗效影响因素。方法 选择南充市川北医学院附属医院2013年2月至2016年9月行89SrCl2治疗的恶性肿瘤骨转移患者99例,分析患者的年龄、性别、肿瘤病理类型、89SrCl2治疗次数、手术切除原发灶、放疗、化疗、肿瘤骨转移的病灶数量、联合止痛药状况以及碱性磷酸酶(ALP)是否会影响89SrCl2的治疗效果。结果 89SrCl2治疗的总有效率为63.6%。单因素分析结果显示不同肿瘤病理类型、不同治疗次数、是否联合放射治疗、是否手术切除原发灶、不同肿瘤骨转移病灶数量及是否联合止痛药患者的治疗效果进行比较,差异具有统计学意义(P<0.05)。logistics回归分析显示,患者的肿瘤病理类型、89SrCl2治疗次数、手术切除原发灶、肿瘤骨转移的病灶数量及联合止痛药是影响89SrCl2疗效的独立因素(P<0.05)。结论 肿瘤病理类型、89SrCl2治疗次数、手术切除原发灶、肿瘤骨转移病灶数量以及联合止痛药能影响89SrCl2治疗恶性肿瘤骨转移的疗效。
英文摘要:
      Objective To investigate the influencing factors of the treatment of bone metastases of malignant tumors with strontium chloride (89SrCl2).Methods Ninety-nine patients of bone metastases were collected from Nanchong Affiliated Hospital of North Sichuan Medical College from Feb 2013 to Sept 2016, and grouped according to their treatment result. Whether the age, sex, pathological type of tumor, the treatment times of 89SrCl2, operation, radiotherapy, chemotherapy, number of bone metastases, analgesics and the level of alkaline phosphatase (ALP) had influence on the treatment result of 89SrCl2 was analyzed.Results The total efficiency of 89SrCl2 treatment was 63.6%. The univariate analysis showed that different tumor pathological types, different times of treatment, whether combined with radiotherapy, surgical resection or not, the number of different tumor bone metastases, and whether combined with analgesics were statistically significant (P< 0.05). These factors were brought into multivariate Logistics regression analysis to show that the pathological type of the tumor, the times of 89SrCl2 treatment, operation, the number of tumor bone metastases, and whether combined with analgesic are the independent factors affecting the efficacy of 89SrCl2.Conclusion The pathological type of tumor, the times of patients treated with 89SrCl2, operation, the number of tumor bone metastases and whether combined with analgesic affect the efficacy of 89SrCl2.
查看全文   查看/发表评论  下载PDF阅读器
关闭